{
  "column-order": [
    "Ampicillin",
    "Amoxicillin/clavulanate",
    "Ampicillin/sulbactam",
    "Piperacillin/tazobactam",
    "Cefazolin",
    "Cefoxitin",
    "Cefepime",
    "Ceftazidime",
    "Ceftriaxone",
    "Ertapenem",
    "Meropenem",
    "Ciprofloxacin",
    "Levofloxacin",
    "Gentamicin",
    "Tobramycin",
    "Amikacin",
    "Tetracycline",
    "Minocycline",
    "Trimethoprim/sulfamethoxazole",
    "Nitrofurantoin",
    "Clindamycin",
    "Erythromycin",
    "Azithromycin",
    "Oxacillin",
    "Penicillin",
    "Vancomycin",
    "Rifampin",
    "Daptomycin",
    "Linezolid",
    "Gentamicin-Synergy",
    "Streptomycin-Synergy"
  ],
  "row-order": [
    "ESCHERICHIA COLI",
    "KLEBSIELLA PNEUMONIAE",
    "ENTEROBACTER CLOACAE COMPLEX",
    "PROTEUS MIRABILIS",
    "SERRATIA MARCESCENS",
    "PSEUDOMONAS AERUGINOSA",
    "ENTEROCOCCUS SP., VSE",
    "ENTEROCOCCUS SP., VRE",
    "STAPH. AUREUS, MSSA",
    "STAPH. AUREUS, MRSA",
    "STAPHYLOCOCCUS EPIDE-",
    "STENOTROPH MALTOPHILIA COMM WIDE",
    "ACINETOBACT BAUMANII COMM WIDE",
    "STREP PNEUMONIAE COMM WIDE",
    "HAEM INFLUENZAE COMM WIDE"
  ],
  "footnotes": [
    "Note: isolates from all sources; urine, blood, respiratory, wound, etc.",
    "For uncomplicated UITâ€™s, Cefazolin MIC results less than or equal to 16 mcg/ml predict susceptibility of the following oral cephalosporins: cefactor, cefdinnir, cefpodoxime, cefprozil cefuroxime and cephalexin.",
    "Oxacillin susceptible Staph are also susceptible to other penicillinase resistant penicillins, betalactam/betalactamase inhibitor combinations, cephems,and carbapenems FDA approved to treat Staph infections.",
    "Gentamicin and Rifampin may be used in combination with other drugs against Staph isolates.",
    "The percentage that are greater than or equal to 80% susceptibility are potentially useful for empiric therapy."
  ],
  "resistance-rates": []
}
